Abstract
A review of 19 adult patients with alpha-1-antitrypsin deficiency (A1AT deficiency) and chronic liver disease revealed a late onset of symptomatic hepatic abnormalities in this condition. Thirteen patients (68%) were 60 years or older when the liver disease was discovered. The mean age of the patients with the ZZ, SZ, and MZ phenotypes was 58, 66, and 72.5 years, respectively; this suggested a later onset of the liver disease in the heterozygotes. At the time of diagnosis, the hepatic condition usually was advanced; in eight patients (42%) the survival was less than two years. The most important associated condition was chronic obstructuve lung disease which was found in 10 patients (53%). We conclude that advanced age and the high incidence of obstructive lung disease make it unlikely that liver transplantation will become a common therapeutic option for adult patients with A1AT deficiency and associated liver disease. Periodic screening of liver function may be indicated in patients with A1AT deficiency so that chronic liver disease can be diagnosed early, particularly if current attempts to develop effective medical therapy for this condition are successful.
Similar content being viewed by others
References
National Institutes of Health Consensus Development Conference Statement. Liver Transplantation, June 20–23, 1983. Hepatology 4:107S–110S, 1984
Kueppers F: Determination of alpha-1-antitrypsin phenotypes by isoelectric focusing in polyacrylamide gells. J Lab Clin Med 88:151–155, 1976
Sharp HL, Bridges RA, Krivit W, Freier EF: Cirrhosis associated with alpha-1-antitrypsin deficiency: A previously unrecognized inherited disorder. J Lab Clin Med 73:934–939, 1969
Larsson C: Natural history and life expectancy in severe alpha-1-antitrypsin deficiency, PiZ. Acta Med Scand 204: 345–351, 1978
Eriksson, S, Carlson J, Valez R: Risk of cirrhosis and primary liver cancer in alpha1-antitrypsin deficiency. N Engl J Med 314:736–739, 1986
Eriksson S: Liver disease and intermediate alpha-1-antitrypsin deficiency. Acta Med Scand 210:241–244, 1981
Campra JL, Craig JR, Peters RL, Reynolds TB: Cirrhosis associated with partial deficiency of alpha-1-antitrypsin in an adult. Ann Intern Med 78:233–238, 1973
Fisher RL, Taylor L, Sherlock S: Alpha-1-antitrypsin deficiency in liver disease: The extent of the problem. Gastroenterology 71:646–651, 1976
Hodges JR, Millward-Sadler GH, Barbatis C, Wright R: Heterozygous MZ alpha-1-antitrypsin deficiency in adults with chronic active hepatitis and cryptogenic cirrhosis. N Engl J Med 304:557–560, 1981
Triger DR, Millward-Sadler GH, Zaykowski AA, Trowell J, Wright R: Alpha-1-antitrypsin deficiency and liver disease in adults. Q J Med 45:351–372, 1976
Eriksson SG: Liver disease in α1-antitrypsin deficiency. Aspects of incidence and prognosis. Scand J Gastroenterol 20:907–911, 1985 (editorial)
Cox DW, Smyth S: Risk for liver disease in adults with alpha-1-antitrypsin deficiency. Am J Med 74:221–227, 1983
Thatcher BS, Winkelman EI, Tuthill RJ: Alpha 1-antitrypsin deficiency presenting as cryptogenic cirrhosis in adults over 50. J Clin Gastroenterol 7:405–408, 1985
Hood JM, Koep LJ, Peters RL, Schroter GPJ, Weil R, Redeker A, Starzl TE: Liver transplantation for advanced liver disease with alpha 1-antitrypsin deficiency. N Engl J Med 302:272–275, 1980
Scharschmidt BF: Human liver transplantation: analysis of data on 540 patients from four centers. Hepatology 4:955–1015, 1984
Gadek JE, Fulmer JD, Gelfand JA, Fraub MM, Petty TL, Crystal RG: Danazol-induced augmentation of serum alpha-1-antitrypsin levels in individuals with marked deficiency of this antiprotease. J Clin Invest 66:82–87, 1980
Gadek JE, Crystal RG: Experience with replacement therapy in the destructive lung disease associated with severe alpha-1-antitrypsin deficiency. Am Rev Respir Dis 127:545–546, 1983
Rosenberg S, Barr PJ, Najarian RC, Hallewell RA: Synthesis in yeast of a functional oxidation-resistant mutant of recessive alpha-1-antitrypsin. Nature 312:77–80, 1984
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rakela, J., Goldschmiedt, M. & Ludwig, J. Late manifestation of chronic liver disease in adults with alpha-1-antitrypsin deficiency. Digest Dis Sci 32, 1358–1362 (1987). https://doi.org/10.1007/BF01296661
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01296661